Frontiers in Cardiovascular Medicine

FEBRUARY 17, 2025

IntroductionSince TAVR was approved for lower-risk aortic stenosis (AS) patients, managing post-implantation conduction disturbances has become crucial, especially with self-expanding heart valves (SEV).

Pacemaker 52

Pacemaker Aortic Stenosis Aortic valve 52

Frontiers in Cardiovascular Medicine

AUGUST 7, 2024

However, with the compelling evidence on the safety and efficacy of transcatheter aortic valve replacement (TAVR), it has become the gold standard treatment option for many patients with symptomatic severe AS. Transfemoral access has been the preferred method for transcatheter heart valve delivery.

Aortic valve 98

Aortic valve Aortic TAVR Peripheral Arterial Disease 98

DAIC

MAY 6, 2024

The first cases were performed by Dr. Tamim Nazif , Director of Clinical Research, Dr. Susheel Kodali , Professor of Medicine and Director of the Structural Heart and Valve Center , and Dr. Isaac George , Surgical Director of the Heart Valve Center. Teleflex received 510(k) clearance from the U.S.

TAVR 105

TAVR Aortic valve Aortic Technology 105

DAIC

MARCH 12, 2024

A cost-effectiveness analysis demonstrates the positive economic value of transcatheter aortic valve replacement (TAVR) using Evolut TAVR compared to surgical aortic valve replacement (SAVR) for low-risk patients. At Medtronic, we continue to emphasize that valve design matters. healthcare system perspective.

TAVR 52

TAVR Aortic valve Aortic Stenosis 52

DAIC

MARCH 15, 2024

Widely recognized for pioneering innovative concepts and techniques in TAVR, Tang has set contemporary standards in the field. His impressive international academic collaborations include the establishment of multiple global registries and the training of heart teams in structural heart imaging and procedures worldwide.

TAVR 105

TAVR Academic Education Cardiovascular Surgery 105

DAIC

MARCH 15, 2024

Widely recognized for pioneering innovative concepts and techniques in TAVR, Tang has set contemporary standards in the field. His impressive international academic collaborations include the establishment of multiple global registries and the training of heart teams in structural heart imaging and procedures worldwide.

TAVR 52

TAVR Academic Education Cardiovascular Surgery 52

DAIC

APRIL 9, 2024

The SMART trial is the first randomized head-to-head comparison of the two most widely used TAVR devices—the supra-annular self-expanding Evolut PRO/PRO+/FX and the balloon-expandable SAPIEN 3/3 Ultra. percentage points—in one-year bioprosthetic valve dysfunction favoring the Evolut platform. of those receiving the SAPIEN valve.

TAVR 59

TAVR Aortic valve Aortic Anatomy 59